AFT Pharma resets on US after setback

27.7.22 AFT Pharmaceuticals’ Pascomer clinical study in the US has been completed and not with the outcome hoped. The medicine did not reach the threshold on the IGA scale that the US Food and Drug Administration (FDA) considered necessary for its registration in the US as topical treatment for facial angiofibromas AFT also announced its […]